Barinthus Biotherapeutics plc. — Form 8-K
Filed September 9, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
Barinthus Biotherapeutics plc filed an 8-K on 2026-09-09 disclosing termination of a material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or listing failure (Item 3.01), material modifications to security holder rights (Item 3.03), and changes in control of the registrant (Item 5.01). The filing document headers indicate these events occurred but specific counterparties, dollar amounts, share counts, and transaction dates are not provided in the accessible text—only item references are visible.
Why this rating
Multiple material events (delisting, control change, agreement termination, acquisition) at a $13.7M company represent existential risk. Delisting alone is business-threatening; combined with control change, this is trajectory-altering.
Extracted items
- 1.02 agreement termination
- 2.01 acquisition/disposition
- 3.01 delisting notice
- 3.03
- 5.01 change in control
- 9.01 exhibits
Tradability signal
SHORT
conviction 55/100 · expected -2.49% over 4 hrs
SHORT (drift): bad news keeps sliding after dissemination — our one persistent measured edge. Similar past filings (19 in this cell) moved +5.77% in the called direction over 4 hrs; shrunk for sample size that's a +2.49% edge. Caution: sub-$5 shorts can be hard to borrow — treat as avoid-longs if no locate. Exit plan: HARD stop 5% against entry — default width (volatility unmeasured), fixed, not trailing (trails test terribly on these names) — time exit 4 hrs.
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
at our read · unknown $0.74 | +10 min · unknown $0.74 ▲ 0.00% | +30 min · unknown $0.74 ▲ 0.00% | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; sessions other than regular hours are labeled. Not investment advice. How accurate are our calls? →
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.